Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD.
Laboratory of Clinical Infectious Diseases, National Institutes of Health, Bethesda, MD.
J Exp Med. 2018 Apr 2;215(4):1079-1090. doi: 10.1084/jem.20170369. Epub 2018 Feb 28.
Appropriate regulation of IL-17 production in the host can mean the difference between effective control of pathogens and uncontrolled inflammation that causes tissue damage. Investigation of conventional CD4 T cells (Th17 cells) has yielded invaluable insights into IL-17 function and its regulation. More recently, we and others reported production of IL-17 from innate αβ+ T cell populations, which was shown to occur primarily via IL-23R signaling through the transcription factor STAT-3. In our current study, we identify promyelocytic leukemia zinc finger (PLZF)-expressing iNKT, CD4/CD8, and CD4/CD8 (DN) αβ+T cells, which produce IL-17 in response to TCR and IL-1 receptor ligation independently of STAT-3 signaling. Notably, this noncanonical pathway of IL-17 production may be important in mucosal defense and is by itself sufficient to control pathogenic infection at the ocular surface.
适当调节宿主中 IL-17 的产生,可以决定有效控制病原体和不受控制的炎症之间的区别,后者可导致组织损伤。对传统 CD4 T 细胞(Th17 细胞)的研究为 IL-17 的功能及其调节提供了宝贵的见解。最近,我们和其他人报道了先天 αβ+T 细胞群产生 IL-17 的情况,研究表明,这主要是通过转录因子 STAT-3 介导的 IL-23R 信号发生的。在我们目前的研究中,我们鉴定出表达早幼粒细胞白血病锌指蛋白(PLZF)的 iNKT、CD4/CD8 和 CD4/CD8(DN)αβ+T 细胞,它们可独立于 STAT-3 信号通过 TCR 和 IL-1 受体的结合来产生 IL-17。值得注意的是,这种非典型的 IL-17 产生途径可能在黏膜防御中很重要,其本身足以控制眼表面的致病性感染。